8-K/A XBRL

8-K/A

Company: SUPERNUS PHARMACEUTICALS, INC.
Filed: August 24, 2020
Period of Report: June 9, 2020
Accession Number: 0001356576-20-000059

View Document ↗ View on SEC.gov ↗